The room was comfortable, with snacks and TV and the chairs Were super cozy with a nice soft blanket
Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists, widely prescribed for type 2 diabetes and weight management, are known for their metabolic benefits but may have unrecognized side effects
Why would my clinician care about my menopause history and recent weight changes
Approval could enable healthcare providers to add retatrutide to their toolbox when treating obesity, particularly for individuals who have not responded to other treatments
Oh, look at my handsome boy back there
Some of these studies are looking into GLP-1 positive effects like: Improved heart health Improved kidney function Reduced inflammation Improved brain health Improved mental health Improved sleep apnea Reduced risk of neurocognitive disorders Improved liver health While at REV we strictly use these medications for weight management, its interesting to see how theyre being studied around the world